CD4 and neoplasm: For example, miR-142-5p overexpression inhibits pancreatic cancer growth by targeting PD-L1 expression on tumor cells, resulting in an increase in IFN- and TNF-, an increase in CD4+ and CD8+ T lymphocytes, and a decrease in PD-1 T lymphocytes [125].